Cassiopea enters into loan agreement with Cosmo Pharmaceuticals NV
Cassiopea SpA, a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products, announced today that it has increased its cash position in an attractive non-dilutive manner allowing the company to continue to invest in its attractive pipeline.